These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 10175911)

  • 1. Stent wars. Guidant beats back market leader Johnson & Johnson with new device.
    Hensley S
    Mod Healthc; 1998 Jan; 28(2):49. PubMed ID: 10175911
    [No Abstract]   [Full Text] [Related]  

  • 2. Stent prices starting to retreat.
    Hensley S
    Mod Healthc; 1999 Jul; 29(30):34. PubMed ID: 10539351
    [No Abstract]   [Full Text] [Related]  

  • 3. As technology races for the stars, so do costs.
    Ford RL
    Hosp Mater Manage; 1996 Aug; 21(8):18. PubMed ID: 10159426
    [No Abstract]   [Full Text] [Related]  

  • 4. [The current status of the coronary stent].
    Macaya C
    Rev Clin Esp; 1993 May; 192(8):361-4. PubMed ID: 8511373
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiac relief. Stent prices could drop with FDA approvals ahead.
    Hensley S
    Mod Healthc; 1997 Jul; 27(28):86. PubMed ID: 10168525
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial.
    Cohen DJ; Bakhai A; Shi C; Githiora L; Lavelle T; Berezin RH; Leon MB; Moses JW; Carrozza JP; Zidar JP; Kuntz RE;
    Circulation; 2004 Aug; 110(5):508-14. PubMed ID: 15262844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Market briefing: 'dollars and stents': new technology will have major impact on heart care.
    Russ Coiles Health Trends; 2002 Dec; 15(2):11-2. PubMed ID: 12536884
    [No Abstract]   [Full Text] [Related]  

  • 8. Competition propping up. Second drug-eluting stent will be cheaper, plentiful.
    Becker C
    Mod Healthc; 2004 Mar; 34(11):12. PubMed ID: 15069793
    [No Abstract]   [Full Text] [Related]  

  • 9. More stent problems. Boston Scientific recall could drive business to J&J.
    Becker C
    Mod Healthc; 2004 Jul; 34(30):17-9. PubMed ID: 15301058
    [No Abstract]   [Full Text] [Related]  

  • 10. Maintaining the flow. In a changing market, GPOs work to keep customers happy.
    Becker C
    Mod Healthc; 2001 Oct; 31(44):24-8, 3. PubMed ID: 11715736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Price survey. Stent prices down, but not enough.
    Hosp Mater Manage; 1999 Apr; 24(4):1, 13-5. PubMed ID: 10351487
    [No Abstract]   [Full Text] [Related]  

  • 12. One-year clinical results and total costs of drug-eluting stents implantation in multivessel coronary artery disease.
    Varani E; Balducelli M; Vecchi G; Aquilina M; Maresta A
    J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):596-601. PubMed ID: 17667030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of reimbursement changes for intracoronary stents on providers and Medicare.
    Vaitkus PT
    Am J Manag Care; 1998 Aug; 4(8):1097-102. PubMed ID: 10182885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of the real-world use of drug-eluting stents at 9-month follow-up: results from the Sicilian DES Registry.
    Tamburino C; Barbagallo R; Capodanno D; di Matteo S; Colombo GL; Recchia M; Ciriminna S;
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):322-9. PubMed ID: 19430343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Welcome drop seen in stent prices.
    Hosp Mater Manage; 2006 Jul; 31(7):1, 5-6. PubMed ID: 16871664
    [No Abstract]   [Full Text] [Related]  

  • 16. Percutaneous transluminal coronary angioplasty hardware entrapment: guidewire entrapment.
    Capuano F; Simon C; Roscitano A; Sinatra R
    J Cardiovasc Med (Hagerstown); 2008 Nov; 9(11):1140-1. PubMed ID: 18852589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Passive stent coatings in the drug-eluting era.
    Menown I; Lowe R; Penn I
    J Invasive Cardiol; 2005 Apr; 17(4):222-8. PubMed ID: 15831978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A two-step program of competitive bidding and physician feedback to reduce coronary angioplasty equipment costs.
    Vaitkus PT; Senesac DL
    Am J Cardiol; 1996 Oct; 78(7):829-32. PubMed ID: 8857493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stent price show signs of declining.
    Hosp Mater Manage; 1998 Apr; 23(4):1, 19. PubMed ID: 10179467
    [No Abstract]   [Full Text] [Related]  

  • 20. Current clinical characteristics and economic impact of subacute stent thrombosis.
    Reynolds MR; Rinaldi MJ; Pinto DS; Cohen DJ
    J Invasive Cardiol; 2002 Jul; 14(7):364-8. PubMed ID: 12082187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.